BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/31/2025 5:47:42 AM | Browse: 79 | Download: 334
 |
Received |
|
2025-08-14 02:32 |
|
Peer-Review Started |
|
2025-08-14 02:32 |
|
First Decision by Editorial Office Director |
|
2025-09-18 09:24 |
|
Return for Revision |
|
2025-09-18 09:24 |
|
Revised |
|
2025-09-27 11:15 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-11-07 02:33 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-11-07 07:16 |
|
Articles in Press |
|
2025-11-07 07:16 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-12-19 02:11 |
|
Publish the Manuscript Online |
|
2025-12-31 05:47 |
| ISSN |
2220-3206 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Psychiatry |
| Manuscript Type |
Observational Study |
| Article Title |
Sustained anxiolytic and antidepressant effects of botulinum toxin A in blepharospasm patients beyond motor symptom control
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Xin-Yi He, Min-Ye Xu, Li-Ying Feng, Jian-Ting Zhang, Li-Zuo Jin, Ling Jin, Jian-Chao Ge, Liang Zhang, Wen-Bin Zhang, Li Zhang, Hong Shen and Jun Yan |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Special Funds of Jiangsu Provincial Key Research and Development Projects |
BE2019612 |
| Scientific Research Project Cooperated by Lanzhou Biotechnology Development Co., Ltd. |
|
| Key R&D Program of Jiangsu Science and Technology Project |
BE2022049, BE2022049-1 |
| National Natural Science Foundation of China |
82171249 |
| Nanjing Rehabilitation Medicine Center Project |
|
| Jiangsu Provincial Health Commission Special Fund for Aging and Health |
|
|
| Corresponding Author |
Jun Yan, Chief Physician, MD, Department of Geriatrics, Affiliated Brain Hospital of Nanjing Medical University, No. 264 Guangzhou Road, Nanjing 210029, Jiangsu Province, China. yanjun2008@njmu.edu.cn |
| Key Words |
Botulinum toxin A; Repeated injection; Neuromuscular junction; Anxiety; Depression; Blepharospasm |
| Core Tip |
Botulinum toxin A (BoNT-A) injection significantly decreases subscale scores of Self-rating Anxiety Scale and Self-rating Depression Scale in blepharospasm even after its effects on facial muscle activity have subside. BoNT-A treatment is an independent factor for the depressive symptom improvement, especially, well-being index in the certain state. BoNT-A might alleviate somatic anxiety but not mental anxiety at a relative long follow-up. Repeated BoNT-A treatment may improve the anxiety and depressive symptoms. |
| Publish Date |
2025-12-31 05:47 |
| Citation |
He XY, Xu MY, Feng LY, Zhang JT, Jin LZ, Jin L, Ge JC, Zhang L, Zhang WB, Zhang L, Shen H, Yan J. Sustained anxiolytic and antidepressant effects of botulinum toxin A in blepharospasm patients beyond motor symptom control. World J Psychiatry 2026; 16(1): 112973 |
| URL |
https://www.wjgnet.com/2220-3206/full/v16/i1/112973.htm |
| DOI |
https://dx.doi.org/10.5498/wjp.v16.i1.112973 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
